AI assistant
Adicet Bio, Inc. — Director's Dealing 2021
Apr 2, 2021
34412_dirs_2021-04-01_324d9326-8852-422c-ab9e-54f232f2085d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-03-30
Reporting Person: Schor Chen (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-30 | Common Stock | S | 3582 | $12.30 | Disposed | 149128 | Indirect |
| 2021-03-30 | Common Stock | S | 2984 | $12.30 | Disposed | 124245 | Indirect |
| 2021-03-30 | Common Stock | S | 5400 | $13.22 | Disposed | 143728 | Indirect |
| 2021-03-30 | Common Stock | S | 4500 | $13.22 | Disposed | 119745 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $11.88 to $12.87, inclusive.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $12.93 to $13.62, inclusive.
F4: Represents 143,728 shares held directly by an irrevocable family trust having an independent trustee.
F5: Represents 119,745 shares held directly by an irrevocable family trust having an independent trustee.